Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 248 (TMEM248) is a **protein-coding gene** located on chromosome 7q11.21 in humans. It codes for a membrane protein predicted to localize primarily at the plasma membrane and has multiple transmembrane domains. TMEM248 is broadly and ubiquitously expressed across human tissues, with low tissue specificity. Its putative function is related to vesicular trafficking and protein binding, but experimental data supporting a precise molecular or cellular role are lacking. The protein is highly conserved across vertebrates and invertebrates. Disease association studies suggest increased expression in various cancers and a possible involvement in neurological, metabolic, and developmental disorders, but it is not established as a therapeutic target, receptor, enzyme, nor any classical druggable protein family. There are currently no approved drugs targeting TMEM248, no specific mechanism of action described for its modulation, and no established use as a biomarker or known safety liabilities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 248 (TMEM248).